TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Alkem Laboratories Ltd. ( (IN:ALKEM) ) has issued an update.
Alkem Laboratories Ltd. has announced the reopening of its trading window on August 18, 2025, following the communication of its financial results for the quarter ending June 30, 2025, to the stock exchanges. This move marks the end of the trading window closure that was in place since June 29, 2025, in compliance with SEBI regulations. The reopening of the trading window is a routine procedure that allows stakeholders to resume trading activities, reflecting the company’s adherence to regulatory requirements and transparency in financial disclosures.
More about Alkem Laboratories Ltd.
Alkem Laboratories Ltd. operates in the pharmaceutical industry, focusing on the development, manufacture, and sale of pharmaceutical formulations and active pharmaceutical ingredients. The company is known for its wide range of products, including generics, over-the-counter drugs, and nutraceuticals, serving both domestic and international markets.
Average Trading Volume: 44,162
Technical Sentiment Signal: Sell
Current Market Cap: 579B INR
For a thorough assessment of ALKEM stock, go to TipRanks’ Stock Analysis page.